FDA issued a black box warning about the use of Tacrolimus and the development of cancer in animals and humans.
Tacrolimus is a topical drug used for dematitis. It is a chronic condition which the skin becomes inflammed, red, itchy. The inflammation is caused by the activation of immune function of the patient. Tacrolimus is used as topical agent to suppress the function of immune system and inflammation by inhibition of calcineurin. This is an enzyme needed for T cell production. T cells plays a big factor in the activation of immune system.
Answer:
Glycogen
Explanation:
In humans polysacchride is stored in the form of glycogen and used as a source of energy.
When there is myelosuppression, the suggestive finding is
there is a decrease in the platelets and red blood cells. Also called the bone
marrow suppression, myelosuppression is a common side effect of the treatment
of chemotherapy. When this side effect happens, there is a decrease in the production
of blood cells. The result which may be the effect of myelosuppression is a
decrease in one, two or all three types of blood cells. Most patients of
chemotherapy experience a decrease in red blood cells. Another effect is the
decrease of white blood cells by most patients. Myelosuppression will be
subcategorized as neutropenia when chemotherapy results to the reduction of
neutrophils which is a specific type of white blood cells. Thrombocytopenia is
the term for a drop in platelet numbers. This kind of suppression is not that common. Only 10 percent of cancer patients undergo
the negative effects of this kind of suppression.
Answer:
Cyclogenesis occurs frequently on the eastern slopes of the rockies as a result of <u>compressional heating</u>.
